Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

In a phase 3 trial, more deaths due to adverse events were reported in the Trodelvy arm compared with the chemotherapy arm. Gilead has made the decision to withdraw the accelerated approval of ...

Accurately diagnosing and staging patients with upper tract urothelial carcinoma (UTUC) has proven challenging for clinicians. Experts at Memorial Sloan Kettering recently applied genomic ...

Gilead’s Trodelvy has another string to its bow after FDA approval in patients with advanced metastatic urothelial cancer. Trodelvy (sacituzumab govitecan) has been approved for locally ...

Distant metastasis-free survival: the time which cancer does not spread to distant organs ... provide additional support for ...

Arlene Siefker-Radtke, MD, opens a discussion recapping the ESMO 2022 conference surrounding advanced and metastatic urothelial cancer. October 28th 2022EP. 2: Unmet Needs of Patients with Locally ...

Diffuse infiltration of the liver by metastatic renal cell carcinoma. Transverse image of the liver shows a heterogeneous echotexture with diffusely increased echogenicity. This patient proved to ...

Therefore future research should also try to assess whether class I HDACs have a prognostic value in locally advanced invasive or metastatic urothelial cancer.